Inizio Evoke

Interested in targeting HCPs through omnichannel media? Check out our 5 key media planning implications to consider: https://hubs.li/Q02LGQw90 #OmnichannelMarketing #OmnichannelMedia #MediaPlanning #Media #InizioEvokeMedia

Congrats to Jason Spark, President of Biotech, on his appointment to the Board of Directors for the Alzheimer's Association San Diego/Imperial Chapter!   His new role on the board not only highlights his personal dedication to advancing Alzheimer’s disease treatment but also echoes the same dedication and expertise we see him bring to our team every day.   Please join us in celebrating Jason. We look forward to the innovative insights and progress he will bring to the Alzheimer’s community. #AlzheimersDisease #Biotech #LifeSciences #InizioEvokeComms

Kura Oncology, Inc. is on a mission to help patients with cancer lead better, longer lives. Riding a recent wave of preliminary clinical data and media coverage, we collaborated with them to establish a resourceful content hub. Kura’s newsroom features the latest news, multimedia resources, educational information, insights from the team at Kura, and more. Check it out here: https://lnkd.in/gr29UH6D #Oncology #Biotech #HealthMoreHuman #InizioEvokeComms

We know that brands are recognizing the growth opportunity afforded through the strategic crafting of campaigns that speak directly to diverse audiences. Check out the article below as we explore the importance of multicultural advertising for pharmaceutical brands and how it fosters authentic connections with consumers of different ethnicities and cultures.   #MulticulturalMarketing #HealthEquity #Media #CulturalDiversity #InizioEvokeMedia

Unlock invaluable insights into the pervasive impact of bias in healthcare and how it affects patient outcomes globally. In our groundbreaking report, developed in collaboration with University College London’s (UCL) Faculty of Brain Sciences, our research uncovers: ✅ The critical findings from our global systematic review on healthcare professional bias and the impact on patient outcomes ✅ Specific instances of bias in healthcare, including gender disparities and inequalities based on age, race, and ethnicity ✅ How our behaviour change experts can help your business to mitigate these biases Download the full report here: https://bit.ly/3Yh5Kuc #HealthcareBias #UCL #HealthEquity #HealthcareComms #Bias #InizioEvokeEurope

What does Biden's AI executive order mean for healthcare? Our Chief Innovation Officer, Will Reese, and Inizio Medical’s Global Chief Artificial and Augmented Intelligence Officer, Matt Lewis, explore the impact in Inizio’s AI report. Download the report here: https://bit.ly/3LTPB6i #HumanPoweredAI #ReimagineHealth #AI #Commercialization #Healthcare

We're attending the ESMO Congress 2024! We're looking forward to exchanging insights that help shape the future of oncology treatments. Come and talk to our team of experts on booth 431e: https://lnkd.in/e6zh5Njp #ESMO24 #Oncology #ReimagineHealth #OncologyTreatments

Are you headed to #ESMO24? We’re excited to join other industry experts and colleagues across Inizio at one of Europe’s most important gatherings of oncology therapeutic development professionals. Reach out to us to book a meeting with our team here: https://hubs.li/Q02Ky0Wf0 We look forward to seeing you there! #Oncology #OncologyInnovation #PharmaMarketing #InizioEvokeEurope

Our President of Inizio Evoke Comms Europe, Dominic Elliston, tackles the pharma trust gap and proposes actionable strategies in his latest article. Dom delves into the below key strategies:   ✅ Showcasing the real-world impact of treatments ✅ Enhancing accessibility of information ✅ Strengthening partnerships with Patient Advocacy Groups   At Inizio Evoke, we're committed to helping our clients navigate these challenges and build meaningful connections with their audiences.   Read Dom’s full insights: https://bit.ly/4fJKHqs   How do you think we can collectively work to improve trust in our industry?    #HealthcareCommunication #PharmaTrust #PatientEngagement #InizioEvokeComms

We’re excited to congratulate iECURE, inc. for being named to the 2024 Fierce 15 list! iECURE is leading the way with their development of the first knock-in gene insertion treatment approved by the FDA for clinical trials in infants. This recognition is truly well-deserved! Learn more: https://bit.ly/3YEiuem #Biotech #ClientWin #Fierce15 #WeAreFierce #InizioEvokeComms Fierce Biotech